List your tool

Head to head · 2026

AZmed vs PathAI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

AZmed

FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays

4.4Not listed

Visit AZmed (opens AZmed in a new tab)

PathAI

First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp

4.3Not listed

Visit PathAI (opens PathAI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: AZmed does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    AZmed

    4.4 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onAZmedPathAI
Our rating4.4Better4.3
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • FDA-cleared fracture, joint effusion, and dislocation detection (AZtrauma)
  • FDA-cleared chest X-ray triage for nodules, pneumothorax, and pleural effusion (AZchest)
  • Pediatric and adult population coverage
  • Deployed across 1,000+ healthcare facilities in 40 countries
  • Validated on a 258,373-X-ray multi-country clinical study
  • AISight Dx analyzes digital pathology slide images to assist diagnosis
  • FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
  • Predetermined Change Control Plan allows faster future software updates
  • Expanded Labcorp collaboration deploying nationwide as of February 2026
  • FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
Pros
  • Multiple FDA clearances rather than a single narrow approval
  • Large-scale published clinical validation spanning 26 countries and 100 centers
  • Established deployment base (1,000+ facilities) rather than a pre-launch product
  • Genuine FDA clearance for primary diagnosis, not just an assistive tool
  • Predetermined Change Control Plan speeds up future regulatory-approved updates
  • National-scale deployment through Labcorp validates real clinical trust
Cons
  • No public pricing; only reachable through a sales demo
  • Regulatory-grade medical device, so adoption requires procurement and IT integration cycles
  • Built for institutional buyers, not usable by individual clinicians directly
  • Enterprise quote-based pricing requires a sales conversation, no published rates
  • Built specifically for pathology labs, not applicable to other clinical specialties
  • Regulatory-cleared medical device status means slower iteration than software-only tools
CompanyAZmed, founded 2018PathAI, founded 2016

Prices come from each vendor's pricing page, last checked 20260803. Check the vendor before you buy.

FAQ

Questions people ask

Is AZmed better than PathAI?

In our reviews AZmed scores 4.4 and PathAI scores 4.3. The better pick depends on the job. AZmed: FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp.

Which is cheaper, AZmed or PathAI?

AZmed: see pricing. PathAI: see pricing.

Do AZmed and PathAI have free plans?

Neither lists a free plan.

More comparisons